课题基金 / 基金详情

项目摘要

项目成果

HARRY A DAILEY的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):拟议工作的总体目标是获得数据,以便在分子水平上描述末端两个血红素合成途径酶,原卟啉原氧化酶(PRO)和铁螯合酶的功能。当前提案的目标是定义人类PRO和铁螯合酶以及细菌不依赖氧的PRO的催化和结构特征。潜在的蛋白质-蛋白质相互作用涉及这些酶以及细胞色素c和卵黄蛋白将被检查。获得的数据将描述人类自然发生的突变的催化后果,这些突变导致被称为卟啉症的遗传性疾病,这应该对患者的治疗和咨询有价值。这些数据还将确定和描述人类和微生物酶之间存在的任何关键差异。这些结果可能为开发新型抗菌药物奠定基础。本提案的具体目标是:1.)通过使用动力学、位点定向诱变和基于结构的研究来定义人类PRO的结构-功能特征,确定细胞色素c是否是PPO的真正电子受体并表征这种相互作用,并分离和表征细菌不依赖氧的原卟啉原氧化酶。2.)通过使用动力学、定点诱变和基于结构的研究确定铁螯合酶的结构-功能特征,表征铁螯合酶与frataxin相互作用并确定其与环状铁母细胞ERR患者的相关性,并通过定点诱变和体格检查表征动物和细菌铁螯合酶中的[2Fe-2S]簇。3)鉴定和表征铁螯合酶和PPO之间的蛋白质相互作用。
英文摘要
DESCRIPTION (provided by applicant): The overall goals of the proposed work are to obtain data that will allow descriptions at the molecular level how the terminal two heme synthetic pathway enzymes, protoporphyrinogen oxidase (PRO) and ferrochelatase, function. The goals of the current proposal are to define catalytic and structural features of human PRO and ferrochelatase and bacterial oxygen-independent PRO. Potential protein-protein interactions involving these enzymes as well as cytochrome c and frataxin will be examined. The data obtained will describe the catalytic consequences of naturally occurring mutations in humans that lead to the inherited diseases known as porphyrias, and this should be of value in patient treatment and counseling. The data will also identify and characterize any key differences that exist between the human and microbial enzymes. These results may set the stage for development of new classes of antimicrobial agents. Specific aims of this proposal are to: 1.) define structure-function characteristics of human PRO through the use of kinetics, site-directed mutagenesis, and structure-based studies, determine if cytochrome c is a bona fide electron acceptor for PPO and characterize this interaction, and isolate and characterize bacterial oxygen-independent protoporphyrinogen oxidase. 2.) define structure-function characteristics of ferrochelatase through the use of kinetics, site-directed mutagenesis, and structure-based studies, characterize the ferrochelatase:frataxin interaction and determine its relevance to ERR patients with ringed sideroblasts, and characterize the [2Fe-2S] cluster in animal and bacterial ferrochelatases through site-directed mutagenesis and physical examination. 3.) identify and characterize protein-protein interactions between ferrochelatase and PPO.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
Identification and characterization of solvent-filled channels in human ferrochelatase.
人亚铁螯合酶中溶剂填充通道的鉴定和表征。
DOI: 10.1021/bi300598g
发表时间: 2012
期刊: Biochemistry
影响因子: 2.9
作者: [Medlock,AmyE, Najahi-Missaoui,Wided, Ross,TeresaA, Dailey,TamaraA, Burch,Joseph, O'Brien,JessicaR, Lanzilotta,WilliamN, Dailey,HarryA]
通讯作者: Dailey,HarryA
DOI: 10.1016/j.bbamcr.2012.04.009
发表时间: 2012-09
期刊: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
影响因子: 5.1
作者: [Hamza, Iqbal, Dailey, Harry A.]
通讯作者: Dailey, Harry A.
Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases.
红细胞生成原卟啉异二聚亚铁螯合酶的生产和表征。
DOI: 10.1182/blood-2004-12-4661
发表时间: 2005
期刊: Blood
影响因子: 20.3
作者: [Najahi-Missaoui,Wided, Dailey,HarryA]
通讯作者: Dailey,HarryA
DOI: 10.1016/s0021-9258(18)69000-3
发表时间: 1988-03
期刊: The Journal of biological chemistry
影响因子: --
作者: [Gloria Cruz FerreiraS;Tamara L. Andrew;S. W. Karr;Harry A. Daileyg]
通讯作者: Gloria Cruz FerreiraS;Tamara L. Andrew;S. W. Karr;Harry A. Daileyg
共 12 条
    Erythroid heme synthesis regulation via the ferrochelatase [2Fe-2S] cluster
    • 批准号:
      8345972
    • 项目类别:
    • 资助金额:
      $37.13万
    • 财政年份:
      2012
    • 负责人:
      HARRY A DAILEY
    • 依托单位:
    Erythroid heme synthesis regulation via the ferrochelatase [2Fe-2S] cluster
    • 批准号:
      8542341
    • 项目类别:
    • 资助金额:
      $0.74万
    • 财政年份:
      2012
    • 负责人:
      HARRY A DAILEY
    • 依托单位:
    2012 Tetrapyrroles GRC
    • 批准号:
      8390717
    • 项目类别:
    • 资助金额:
      $0.5万
    • 财政年份:
      2012
    • 负责人:
      HARRY A DAILEY
    • 依托单位:
    Erythroid heme synthesis regulation via the ferrochelatase [2Fe-2S] cluster
    • 批准号:
      8495333
    • 项目类别:
    • 资助金额:
      $35.83万
    • 财政年份:
      2012
    • 负责人:
      HARRY A DAILEY
    • 依托单位:
    国内基金
    海外基金
    帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
    • 批准号:
      32170319
    • 项目类别:
      面上项目
    • 资助金额:
      58.00万元
    • 批准年份:
      2021
    • 负责人:
      董春海
    • 依托单位:
    帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
    • 批准号:
      --
    • 项目类别:
      --
    • 资助金额:
      58万元
    • 批准年份:
      2021
    • 负责人:
      董春海
    • 依托单位:
    ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
    番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
    • 批准号:
      31372080
    • 项目类别:
      面上项目
    • 资助金额:
      80.0万元
    • 批准年份:
      2013
    • 负责人:
      杨迎伍
    • 依托单位: